Abstract
Healthcare-associated pneumonia (HCAP) is a unique entity that differs from community-acquired pneumonia in both bacteriology and outcomes and has similarities to hospital-acquired pneumonia and ventilator-associated pneumonia. HCAP patients are at higher risk of potential multidrug-resistant pathogens, including resistant gram-negative organisms, especially Pseudomonas aeruginosa and Acinetobacter spp., but also extended-spectrum β-lactamases (ESBLs). This manuscript reviews the epidemiology, etiology, and clinical outcomes of hospitalized HCAP patients due to gram-negative bacteria. We will focus our attention on the potential multidrug-resistant pathogens to suggest a new treatment approach for these patients.
Original language | English (US) |
---|---|
Pages (from-to) | 61-66 |
Number of pages | 6 |
Journal | Seminars in Respiratory and Critical Care Medicine |
Volume | 30 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2009 |
Keywords
- Healthcare-associated
- Outcomes
- Pneumonia
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine